Ribi, Karin; Luo, Weixiu; Walley, Barbara A; Burstein, Harold J; Chirgwin, Jacquie; Ansari, Rafat H; Salim, Muhammed; van der Westhuizen, Andre; Abdi, Ehtesham; Francis, Prudence A; Chia, Stephen; Harvey, Vernon J; Giobbie-Hurder, Anita; Fleming, Gini F; Pagani, Olivia; Di Leo, Angelo; Colleoni, Marco; Gelber, Richard D; Goldhirsch, Aron; Coates, Alan S; ... (2020). Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy. Breast cancer research and treatment, 181(2), pp. 347-359. Springer 10.1007/s10549-020-05622-5
|
Text
Ribi2020_Article_Treatment-inducedSymptomsDepre__1_.pdf - Published Version Available under License Publisher holds Copyright. Download (1MB) | Preview |
PURPOSE
Sexual dysfunction is an important concern of premenopausal women with early breast cancer. We investigated predictors of sexual problems in two randomized controlled trials.
METHODS
A subset of patients enrolled in TEXT and SOFT completed global and symptom-specific quality-of-life indicators, CES-Depression and MOS-Sexual Problems measures at baseline, six, 12 and 24 months. Mixed models tested the association of changes in treatment-induced symptoms (baseline to 6 months), depression at 6 months, and age at randomization with changes in sexual problems over 2 years.
RESULTS
Sexual problems increased by 6 months and persisted at this level. Overall, patients with more severe worsening of vaginal dryness, sleep disturbances and bone or joint pain at 6 months reported a greater increase in sexual problems at all time-points. Depression scores were significantly associated with sexual problems in the short-term. All other symptoms had a smaller impact on sexual problems. Age was not associated with sexual problems at any time-point.
CONCLUSION
Among several key symptoms, vaginal dryness, sleep disturbance, and bone and joint pain significantly predicted sexual problems during the first 2 years. Early identification of these symptoms may contribute to timely and tailored interventions.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology |
UniBE Contributor: |
Bernhard, Jürg Theodor |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0167-6806 |
Publisher: |
Springer |
Language: |
English |
Submitter: |
Rebeka Gerber |
Date Deposited: |
30 Dec 2020 14:19 |
Last Modified: |
11 Apr 2024 00:25 |
Publisher DOI: |
10.1007/s10549-020-05622-5 |
PubMed ID: |
32274665 |
Uncontrolled Keywords: |
Breast cancer Depression Endocrine treatment Sexual problems Treatment-induced symptoms |
BORIS DOI: |
10.48350/149335 |
URI: |
https://boris.unibe.ch/id/eprint/149335 |